Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Celestial Labs is a drone display company that combines advanced technology with organic performance. The company's proprietary 'Skytheatre' display is a dynamic, safe and green alternative to carbon-intensive fireworks and represents a new frontier for the live event industry. Composed of a creative collective of award-winning filmmakers, musicians, developers, entrepreneurs, and storytellers, the company is constantly pushing the boundaries of drone display innovation, where technology meets imagination. The Human Support division of Celestial is a not-for-profit initiative that aims to lift the spirits of those who witness Celestial's displays whilst imparting crucial information. The company aims to enlist the support and guidance of city leadership partners, industrial conglomerates, and seek grant funding.
days to go:
Stretch
investment:
Withheld
NY Slice has become a Glasgow phenomenon in only 1 year. Acclaimed by critics, bloggers and national media, it is taking the local market by storm. Our authentic New York offering of pizza by the slice & whole pizzas up to 18"s for dine in, takeout or delivery is revolutionising pizza in the City. We have invested significantly in creating and perfecting a model that is easily scalable across the UK & beyond. With the appropriate funding we can grow to from 7 stores in year 1 to 80 in year 5
days to go:
Expired
investment:
Withheld
A new form of electric transport in the bike industry with the use of an affordable and simple conversion kit. Swytch have developed a kinetically rechargeable add-on for existing bikes to convert them into eBikes for a range of up to 50 miles. Funding will result in additional units being manufactured and sold at a 70% margin. The products are available online and currently via 20 independent bike dealers, with over 100 more waiting on stock.
days to go:
Expired
investment:
£349,356
The Nice One App is an on-demand mobile app for van and recovery drivers. A user simply goes on the app, chooses where they want to be picked up from, what size van/recovery truck they need and then their request is sent out to the nearest available driver.
days to go:
Expired
investment:
£65,090
DNApal is a personalised diet, health and fitness app that combines DNA infomation with other factors like age, weight, diet, family history and health goals. Two of the largest consumer DNA companies, 23andMe and Ancestry.com, have tested over 18m people. DNApal is capable of interpreting DNA results from these companies to provide precise recommendations on how to improve diet, hormone balance, weight loss, sleep, fitness & more. The company also won the best pitch at VentureFest 2019 at Oxford Brookes University. DNApal is aiming to launch MVP in January 2020 (iOS). The company is also aiming to recommend further testing and specific supplements where necessary and offer 1:1 consultations with a specialist. With the fund raised, DNApal plans to develop the full scope of the app, weekly goals, content challenges to keep users committed.
days to go:
Expired
investment:
£49,990
Bringing an Italian tradition to the UK, the team at Miccone are raising funds to open their first permanent site in London. 22% of British Adults choose Italian food when eating out, so the team are bringing their experience from an Italian Miccone in Pavia to the streets of London.
days to go:
Expired
investment:
£85,920
The company operates within the Fast Moving Consumer Goods market and will be launching KOKONATA drink product.KOKONATA coconut water is a particular variety of coconut that is indigenous to the tropical island of Sri Lanka called “King Coconut” this is a particular type of Yellow Coconut which is only grown in this region. On the Island, Kokonata coconut trees grow freely and in abundance with little or no human intervention. Its taste and ability to replenish the body make it the premium source of hydration, hence the name “King” of all coconuts.You need to be registered as an investor to see thisJoin Now
days to go:
Expired
investment:
Withheld
